{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-021982","form_type":"8-K","ticker":"SMTI","cik":"0000714256","company_name":"Sanara MedTech Inc.","filed_at":"2024-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.744394+00:00","generated_at":"2026-06-01T07:31:31.460249+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Sanara MedTech Inc. CEO Zachary B. Fleming Resigns, Enters Separation Agreement","bullets":["Zachary B. Fleming resigned as CEO effective May 10, 2024; separation agreement signed May 29, 2024.","Separation benefits include 12 months base salary paid in installments over 12 months.","Company to pay COBRA premiums for Fleming and dependents during the severance period.","50% of unvested restricted stock continues to vest; partial acceleration for tax withholding.","Fleming provides general release and non-disparagement covenant in exchange for benefits."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-021982","json":"https://secwatch.observer/filing/0001493152-24-021982.json","markdown":"https://secwatch.observer/filing/0001493152-24-021982.md","text":"https://secwatch.observer/filing/0001493152-24-021982.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/714256/000149315224021982/0001493152-24-021982-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/714256/000149315224021982/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:31:31.460249+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f2a2855af7","claim":"Zachary B. Fleming resigned as Chief Executive Officer at Sanara MedTech Inc..","evidence_excerpt":"Zachary B. Fleming tendered his resignation as the Chief Executive Officer of Sanara MedTech Inc. (the “Company”), effective as of such date","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/714256/000149315224021982/0001493152-24-021982-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}